## HBAN: Huntington Bancshares Incorporated - XLF: Financial Services

### Executive Summary

No thesis match: MRS_10 -0.8% below STRENGTH zone (3.0-6.0%); PEG 1.85 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-5.5% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($17.07)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 9
- **Sentiment:** Bullish (Bullish: 4, Bearish: 0)

**1. Huntington’s $7.4B Cadence deal gets regulatory sign-off**
- Source: Banking Dive | 20251223T170956 | Somewhat-Bullish | Relevance: 100%
- Huntington Bank's $7.4 billion acquisition of Cadence Bank has received approval from the Office of the Comptroller of the Currency, clearing the final regulatory hurdle. The deal, expected to close on February 1, 2026, will create a $276 billion-asset bank and expand Huntington's footprint significantly, particularly in Texas. This swift approval contrasts sharply with the longer regulatory processes seen under previous administrations.

**2. Huntington Bancshares Inc Announces Regulatory Approval for Cadence Merger**
- Source: TradingView — Track All Markets | 20251223T110803 | Bullish | Relevance: 100%
- Huntington Bancshares Inc (HBAN) announced on December 22, 2025, that it has received all necessary regulatory approvals, including from the Office of the Comptroller of the Currency, for its merger with Cadence Bank. The merger is anticipated to conclude on February 1, 2026, with Huntington National Bank serving as the surviving entity.

**3. Huntington Bancshares Incorporated and Cadence Bank Announce Receipt of Required Regulatory Approval for Pending Merger**
- Source: PR Newswire | 20251222T172000 | Bullish | Relevance: 100%
- Huntington Bancshares Incorporated and Cadence Bank have received the required regulatory approval from the Office of the Comptroller of the Currency for their proposed merger. The merger involves Cadence Bank merging into The Huntington National Bank, with the latter as the surviving entity. The transaction is expected to close on February 1, 2026, pending shareholder approvals and other customary closing conditions.

**4. Video: Huntington Bank’s ‘Three Things Learned this Week’**
- Source: RVBusiness | 20251222T161733 | Neutral | Relevance: 100%
- Huntington Bank's Director of Equity Research, Randy Hare, shares insights on better-than-expected inflation data, holiday spending, and the potential for artificial intelligence in 2026. This video summarizes three key economic observations from the bank's weekly "Three Things We Learned This Week" blog.

**5. Huntington Bancshares Receives OCC Approval For Cadence Bank Merger**
- Source: Nasdaq | 20251223T053133 | Bullish | Relevance: 100%
- Huntington Bancshares Inc. announced that the Office of the Comptroller of the Currency has approved the proposed merger of Cadence Bank with The Huntington National Bank. The merger is expected to close on February 1, 2026. The terms of the transaction were not disclosed.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 2, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-19 | RBC Capital | $20 | $19 | +5% |
| 2025-12-10 | Piper Sandler | $16 | $15 | +7% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-19 | RBC Capital | main | Outperform |
| 2025-12-10 | Piper Sandler | main | Underweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 33 ($0.48M) |
| Sells | 10 ($1.14M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 48.9% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 12.1% (+0.4%)
- Blackrock Inc.: 9.5% (-3.0%)
- State Street Corpora: 5.1% (-0.8%)
- Price (T.Rowe) Assoc: 4.3% (-2.2%)
- Boston Partners: 4.3% (+3.9%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.85 elevated, pricing in significant growth expectations. Quality metrics strong (margin 30%). Balance sheet: strong liquidity (63.0x). Revenue growth strong at 36% YoY. Analyst sentiment positive (2 raises, avg +6%). Insider selling cluster ($1.1M in 90 days), potential headwind. Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $27.9B |
| Beta | 0.98 |
| 52W Range | $11.92 - $18.04 |
| Short Interest | 6.7% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.85 |
| Forward P/E | 11.5 |
| Current P/E | 12.5 |
| YoY Growth | 8.9% |
| EPS Direction | STABLE |

### Technicals

MRS_10 deteriorating from 4.7% to -0.8% (-5.5% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 3.8pp (needs >3.0% for momentum thesis). Full SMA alignment bullish (above 20/50/200 SMAs). OFD pattern: -MTL (Decline).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -0.79% (CS: 54) | Neutral |
| RSI_14 | 65.4 | Neutral |
| MACD Histogram | 0.02 | Bullish |
| vs SMA20 | 1.030x | Above |
| vs SMA50 | 1.090x | Above |
| vs SMA200 | 1.103x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $17.73
- **Stop Loss:** $17.07 (3.7% risk)
- **Target:** $18.39 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 1363
- **Position Value:** $24,165.99
- **Portfolio %:** 24.17%
- **Risk Dollars:** $900.00
- **Risk Per Trade:** 0.90%
- **Modifiers:** L1 120% | L2 75% | Combined 0.90x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with moderate risk appetite in holiday-thinned conditions. VIX at 52-week lows suggests complacency, but modest breadth improvement and stable yields indicate underlying stability. Focus on quality positioning ahead of 2026 catalysts.*

### Earnings

**Next:** 2026-01-22 (Est: $0.24)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.38 | $0.41 | +9.1% |
| 2025Q2 | $0.33 | $0.34 | +1.7% |
| 2025Q1 | $0.31 | $0.34 | +8.5% |
| 2024Q4 | $0.31 | $0.34 | +10.1% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*